Raymond Prudo-Chlebosz

Holdings History for Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX)

Symbol: AKTX on Nasdaq
Investment type: Equity / Ordinary Shares, $0.000000005 par value
Latest Disclosed Shares Owned: 8,391,326,467 shares
Security Ownership %: 8.9%

Ray Prudo, M.D. ownership in Akari Therapeutics Plc Ordinary Shares, $0.000000005 par value (AKTX)

04 Mar 2026 - Ray Prudo, M.D. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,391,326,467 shares of Akari Therapeutics Plc Ordinary Shares, $0.000000005 par value (AKTX). This represents 8.9% ownership of the company. In their previous filing dated 14 Feb 2025, Raymond Prudo-Chlebosz had reported owning 4,926,600,800 shares, indicating an increase of +70%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Ray Prudo, M.D.	8.9%	-4.4%	$2,013,918,352	8,391,326,467	+3,464,725,667	+70%	$0.24	13D/A	02 Mar 2026	04 Mar 2026, 16:52
Ray Prudo, M.D.	9.3%		$6,897,241,120	4,926,600,800			$1.40	13D/A	14 Nov 2024	14 Feb 2025, 17:00